Four-Year Visual Outcomes After Intravitreous Aflibercept for Vision-Threatening Complications of Diabetic Retinopathy. Kanclerz P, Tuuminen R. JAMA 2023;329:1795-1796.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kanclerz P, Tuuminen R. Four-Year Visual Outcomes After Intravitreous Aflibercept for Vision-Threatening Complications of Diabetic Retinopathy. JAMA 2023;329:1795-1796.
PMID: 37219557